logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
9/22/2022 7:27:20 AM U.S. District Court Rules In Favor Of Merck In Sitagliptin Phosphate Patent Lawsuit
9/13/2022 7:27:10 AM Medicenna Announces Clinical Collaboration With Merck To Evaluate MDNA11 With KEYTRUDA In ABILITY Trial
9/13/2022 7:13:12 AM Merck: Health Canada Approves KEYTRUDA For Stage IIB Or IIC Melanoma Following Complete Resection
9/12/2022 9:02:23 AM Astellas Reports Results Of Trial Of PADCEV -KEYTRUDA &PADCEV As Monotherapy In First-Line Advanced Urothelial Cancer
9/9/2022 8:04:52 AM AstraZeneca : LYNPARZA Combination Shows Meaningful Survival Benefit In Ovarian Cancer Across Phase III Trials
8/23/2022 7:21:17 AM Merck Gets Fast Track Designation From FDA For MK-2060, An Investigational Anticoagulant Therapy
8/16/2022 6:49:53 AM Merck And Orna Therapeutics Collaborate To Advance Orna's Next Generation Of RNA Technology
8/3/2022 8:00:31 AM Merck's Phase 3 LEAP-002 Trial Evaluating KEYTRUDA + LENVIMA Vs LENVIMA Monotherapy Fails To Meet Goal